{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013543","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.533168+00:00","generated_at":"2026-05-19T23:50:36.945726+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"medium","headline":"Glucotrack to present first-in-human CBGM data at ADA 85th Scientific Sessions","bullets":["Will present safety & performance data from first-in-human trial of implantable continuous blood glucose monitor (CBGM).","Live presentation by CSO Mark Tapsak on June 21 in Innovation Hub; poster session June 22.","CBGM measures glucose directly from blood, lasts up to 3 years, no on-body wearable.","Company preparing for next clinical phase (long-term feasibility study)."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013543","json":"https://secwatch.observer/filing/0001641172-25-013543.json","markdown":"https://secwatch.observer/filing/0001641172-25-013543.md","text":"https://secwatch.observer/filing/0001641172-25-013543.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000164117225013543/0001641172-25-013543-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000164117225013543/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T23:50:36.945726+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}